Turk J Med Sci
-
The study aims to evaluate the usage of gold weight implants and monitor complaints and comfort of patients. ⋯ The gold weight implantation is an effective, reversible, and easy procedure significantly reducing complaints regarding paralytic lagophthalmos. Early implementation may be beneficial for ocular complications. A dynamic facial reanimation could terminate need of implant.
-
Ganglioside antibodies are identified not only in patients with inflammatory neuropathies but also several central nervous system disorders and paraneoplastic neuropathies. Our aim was to investigate whether ganglioside antibodies are found in autoimmune encephalitis patients and may function as a diagnostic and prognostic biomarker. ⋯ Serum ganglioside IgM antibodies may infrequently emerge during the clinical course of autoimmune limbic encephalitis without evident polyneuropathy. Absence of the IgG response suggests that these antibodies might have developed as a hyperacute immune response to neuro-axonal destruction. Nevertheless, potential impact of ganglioside antibodies on axonal degeneration and neuronal loss in limbic encephalitis pends to be further investigated.
-
To the Editor, We read with great interest the articles entitled "An evaluation of the effects of caffeic acid phenethyl ester and Ankaferd blood stopper on secondary wound healing of oral mucosal tissue", and "Antiinfective and woundhealing pleiotropic actions of Ankaferd hemostat" published recently in the Turkish Journal of Medical Sciences [1,2]. ⋯ The authors declare that there is no conflict of interest.
-
Bevacizumab is a chemotherapeutic drug, which selectively binds to vascular endothelial growth factor (VEGF) and mainly inhibits angiogenesis and neovascularization. We aimed to study the possible effects of bevacizumab on right ventricular pressure (RVP), right ventricular hypertrophy, and VEGF, in hypoxia - induced pulmonary hypertension (PH) rat model. ⋯ Bevacizumab, which is indeed an antineoplastic agent, might have a favorable effect on hypoxia - induced pulmonary hypertension.
-
To the Editor, In February 2020, the Word Health Organization (WHO) announced the name for a disease caused by the SARS-CoV virus: coronavirus disease 2019 (COVID-19) 1. On March 11, 2020, the first case was officially confirmed in Turkey2, and the WHO declared COVID-19 a pandemic. ⋯ The authors have no conflicts of interest to declare. The authors received no financial support for the research, authorship, and/or publication of this article.